Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
829 studies found for:    "Crohns disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Crohns disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs
Conditions: Crohn's Disease;   Ileitis;   Ileo-colonic and Colonic Crohn's Disease;   Granulomatous Colitis;   Regional Enteritis;   Ulcerative Colitis
Interventions: Procedure: lumbar puncture;   Drug: lumbar puncture
2 Recruiting High-dose Cyclophosphamide for Severe Refractory Crohn Disease
Conditions: Crohn's Disease;   Crohn Disease
Intervention: Drug: High-dose Cyclophosphamide
3 Completed Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Tacrolimus
4 Completed Capsule Endoscopy Crohn's Disease Activity Index - Validation Multi Center Study
Condition: Crohn's Disease
Intervention: Device: Given® Diagnostic System including PillCamTM SB Capsules
5 Not yet recruiting AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PEri-fistula iNjEctions (GALENE)
Conditions: Crohn's Disease;   Fistulizing Crohn's Disease;   Stem Cells
Intervention: Drug: Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)
6 Terminated High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children
Condition: Crohn's Disease
Intervention: Drug: PASER or placebo granules
7 Unknown  Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease
Condition: Crohn Disease
Interventions: Drug: Infliximab with azathioprine (IIFX + AZA);   Drug: Infliximab (IFX alone)
8 Completed
Has Results
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: growth hormone;   Drug: cortecosteroid
9 Completed Evaluation of the Applicability of the CDEIS to Data Obtained by the Colonic Capsule Endoscopy in Crohn Disease
Condition: Crohn Disease
Intervention: Procedure: Colon Capsule Endoscopy
10 Completed A Study of TRK-170 for the Treatment of Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: TRK-170;   Drug: Placebo
11 Completed
Has Results
Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease
Condition: Crohn's Disease
Intervention: Device: Capsule Endoscopy
12 Completed Study Evaluating rhIL-11 in Active Crohn's Disease
Conditions: Crohn Disease;   Inflammatory Bowel Disease
Intervention: Drug: Recombinant Human Interleukin-11 (rhIL-11)
13 Completed Trial of a Treatment Algorithm for the Management of Crohn's Disease
Condition: Crohn's Disease
Intervention: Other: Treatment Algorithm for Crohn's Disease
14 Completed Dietary Treatment of Crohn's Disease
Conditions: Crohn's Disease;   Inflammatory Bowel Disease
Interventions: Dietary Supplement: Time and attention + fructo-oligosaccharide placebo;   Dietary Supplement: dietary therapy + fructo-oligosaccharide placebo;   Drug: Time and attention + active fructooligosaccharide supplementation
15 Recruiting Induction of Clinical Response Using Rifaximin in Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Placebo Comparator;   Drug: Rifaximin
16 Completed Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
Condition: Crohn Disease
Intervention: Drug: Teduglutide (ALX-0600)
17 Completed Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
Condition: Crohn Disease
Intervention: Drug: Physician standard-of-care
18 Terminated AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: AMG 827 350 MG;   Drug: AMG 827 210 MG;   Drug: AMG 827 700 MG;   Drug: Placebo
19 Unknown  Psychology of Crohn's Disease
Condition: Crohn's Disease
Intervention: Behavioral: Questionnaire
20 Active, not recruiting A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years